» Authors » John D Graef

John D Graef

Explore the profile of John D Graef including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 12
Citations 148
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Graef J, Wu H, Ng C, Sun C, Villegas V, Qadir D, et al.
Eur J Neurosci . 2019 Dec; 51(10):2143-2157. PMID: 31880363
Fragile X syndrome (FXS) is the most common genetic form of intellectual disability caused by a CGG repeat expansion in the 5'-UTR of the Fragile X mental retardation gene FMR1,...
2.
Bristow L, Gulia J, Weed M, Srikumar B, Li Y, Graef J, et al.
J Pharmacol Exp Ther . 2017 Sep; 363(3):377-393. PMID: 28954811
()-3-((3S,4S)-3-fluoro-4-(4-hydroxyphenyl)piperidin-1-yl)-1-(4-methylbenzyl)pyrrolidin-2-one (BMS-986169) and the phosphate prodrug 4-((3,4)-3-fluoro-1-((R)-1-(4-methylbenzyl)-2-oxopyrrolidin-3-yl)piperidin-4-yl)phenyl dihydrogen phosphate (BMS-986163) were identified from a drug discovery effort focused on the development of novel, intravenous glutamate -methyl-d-aspartate 2B receptor (GluN2B) negative...
3.
Post-Munson D, Pieschl R, Molski T, Graef J, Hendricson A, Knox R, et al.
Eur J Pharmacol . 2017 Jan; 799:16-25. PMID: 28132910
The alpha7 (α7) nicotinic acetylcholine receptor is a therapeutic target for cognitive disorders. Here we describe 3-(3,4-difluorophenyl)-N-(1-(6-(4-(pyridin-2-yl)piperazin-1-yl)pyrazin-2-yl)ethyl)propanamide (B-973), a novel piperazine-containing molecule that acts as a positive allosteric modulator of...
4.
Newberry K, Wang S, Hoque N, Kiss L, Ahlijanian M, Herrington J, et al.
J Neurophysiol . 2016 Apr; 115(6):3217-28. PMID: 27052585
In vitro phenotypic assays of sensory neuron activity are important tools for identifying potential analgesic compounds. These assays are typically characterized by hyperexcitable and/or abnormally, spontaneously active cells. Whereas manual...
5.
Graef J, Newberry K, Newton A, Pieschl R, Shields E, Luan F, et al.
Brain Res . 2015 Mar; 1609:31-9. PMID: 25796435
The long lasting antidepressant response seen following acute, i.v. ketamine administration in patients with treatment-resistant depression (TRD) is thought to result from enhanced synaptic plasticity in cortical and hippocampal circuits....
6.
Johnston T, Huot P, Fox S, Koprich J, Szeliga K, James J, et al.
Neuropharmacology . 2013 Jun; 73:337-47. PMID: 23770260
Long-term L-DOPA treatment for Parkinson's disease (PD) is limited by motor complications, particularly L-DOPA-induced dyskinesia (LID). A therapy with the ability to ameliorate LID without reducing anti-parkinsonian benefit would be...
7.
Graef J, Wei H, Lippiello P, Bencherif M, Fedorov N
J Neurosci Methods . 2012 Oct; 212(2):228-33. PMID: 23099344
Here we validate the design and use of a novel, customized electrophysiology system (Slice XVIvo™) that is capable of recording from 16 independent brain slices. The system consists of 16...
8.
Wiggins W, Graef J, Huitt T, Godwin D
Alcohol Clin Exp Res . 2012 Oct; 37(3):372-82. PMID: 23078554
Background: Chronic ethanol (EtOH) leads to disruptions in resting electroencephalogram (EEG) activity and in sleep patterns that can persist into the withdrawal period. These disruptions have been suggested to be...
9.
Graef J, Benson L, Sidach S, Wei H, Lippiello P, Bencherif M, et al.
J Biomol Screen . 2012 Sep; 18(1):116-27. PMID: 22960782
High-throughput compound screening using electrophysiology-based assays represents an important tool for biomedical research and drug discovery programs. The recent development and availability of devices capable of performing high-throughput electrophysiology-based screening...
10.
Fedorov N, Benson L, Graef J, Hyman J, Sollenberger J, Pettersson F, et al.
J Neurosci Methods . 2012 Feb; 206(1):23-33. PMID: 22342972
Fast solution exchange techniques have revolutionized the study of synaptic transmission and promise to remain an important neuroscience research tool. Here we provide evidence for the hypothesis that using continuous,...